FY2016 EPS Estimates for The Advisory Board Company (ABCO) Cut by First Analysis

The Advisory Board Company (NASDAQ:ABCO) – Equities research analysts at First Analysis lowered their FY2016 earnings per share estimates for The Advisory Board Company in a research note issued to investors on Monday. First Analysis analyst now forecasts that the brokerage will earn $1.77 per share for the year, down from their prior estimate of $1.84. First Analysis also issued estimates for The Advisory Board Company’s Q3 2017 earnings at $0.46 EPS and FY2017 earnings at $1.97 EPS.

The Advisory Board Company (NASDAQ:ABCO) last released its quarterly earnings data on Tuesday, November 1st. The company reported $0.28 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.40 by $0.12. The business had revenue of $200.50 million for the quarter, compared to analysts’ expectations of $203.35 million. The Advisory Board Company had a negative net margin of 5.77% and a positive return on equity of 11.28%. The Advisory Board Company’s revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the company earned $0.33 earnings per share. ILLEGAL ACTIVITY NOTICE: This report was first posted by BBNS and is the propert of of BBNS. If you are accessing this report on another domain, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be read at https://baseballnewssource.com/markets/fy2016-eps-estimates-for-the-advisory-board-company-abco-cut-by-first-analysis/344956.html.

Several other equities analysts have also issued reports on ABCO. Canaccord Genuity set a $50.00 price target on The Advisory Board Company and gave the stock a “buy” rating in a research report on Wednesday, September 28th. Cantor Fitzgerald set a $37.00 price target on The Advisory Board Company and gave the stock a “hold” rating in a research report on Wednesday, November 2nd. Credit Suisse Group reiterated a “buy” rating and issued a $50.00 price objective on shares of The Advisory Board Company in a report on Friday, September 16th. Stifel Nicolaus reduced their price objective on The Advisory Board Company from $45.00 to $43.00 and set a “hold” rating for the company in a report on Wednesday, November 2nd. Finally, Barclays PLC lifted their price objective on The Advisory Board Company from $44.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, September 30th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and ten have assigned a buy rating to the stock. The Advisory Board Company presently has an average rating of “Hold” and a consensus target price of $42.38.

The Advisory Board Company (NASDAQ:ABCO) traded up 1.487% during midday trading on Wednesday, reaching $35.825. 141,857 shares of the company’s stock traded hands. The Advisory Board Company has a one year low of $18.87 and a one year high of $48.86. The stock’s market cap is $1.44 billion. The stock’s 50 day moving average price is $33.88 and its 200-day moving average price is $38.68.

In related news, CFO Michael T. Kirshbaum sold 2,400 shares of the business’s stock in a transaction that occurred on Thursday, October 20th. The stock was sold at an average price of $42.80, for a total value of $102,720.00. Following the transaction, the chief financial officer now directly owns 45,503 shares of the company’s stock, valued at approximately $1,947,528.40. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Hoose Mary Van sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $33.49, for a total value of $66,980.00. Following the completion of the transaction, the insider now directly owns 37,386 shares in the company, valued at $1,252,057.14. The disclosure for this sale can be found here. 2.90% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: This report was first posted by BBNS and is the propert of of BBNS. If you are accessing this report on another domain, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be read at https://baseballnewssource.com/markets/fy2016-eps-estimates-for-the-advisory-board-company-abco-cut-by-first-analysis/344956.html.

Hedge funds and other institutional investors have recently bought and sold shares of the company. D.A. Davidson & CO. boosted its position in The Advisory Board Company by 23.9% in the third quarter. D.A. Davidson & CO. now owns 14,647 shares of the company’s stock worth $653,000 after buying an additional 2,826 shares in the last quarter. LPL Financial LLC acquired a new position in The Advisory Board Company during the third quarter worth approximately $247,000. Credit Suisse AG boosted its position in The Advisory Board Company by 1,301.6% in the third quarter. Credit Suisse AG now owns 518,132 shares of the company’s stock worth $23,183,000 after buying an additional 481,164 shares in the last quarter. Chartwell Investment Partners LLC acquired a new position in The Advisory Board Company during the third quarter worth approximately $3,917,000. Finally, Bell State Bank & Trust purchased a new stake in shares of The Advisory Board Company during the third quarter valued at about $252,000.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

5 Day Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with our FREE daily email newsletter.

 

Latest News

Toronto and Jose Bautista Agree to One-Year Deal
Toronto and Jose Bautista Agree to One-Year Deal
Orioles Talking Contract with Slugger Jose Bautista
Orioles Talking Contract with Slugger Jose Bautista
Criticism During World Series Humorous to Joe Maddon
Criticism During World Series Humorous to Joe Maddon
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Los Angeles Dodgers Awaiting Decision by Twins on Brian Dozier
Manny Ramirez Returning to Play Baseball in Japan
Manny Ramirez Returning to Play Baseball in Japan
Rajai Davis Anxious to Start Second Stint With Oakland
Rajai Davis Anxious to Start Second Stint With Oakland


Leave a Reply

 
© 2006-2017 BBNS.